Skip to main content

Drug testing could get a boost from MIT’s ‘body on a chip’

Felice Frankel
Felice Frankel

Drug testing is tricky business but it’s an essential step to bringing safer medications to the market. Pharmaceutical drugs are designed for a specific purpose, to treat a given ailment, but often come with a slew of “side effects may include…” — drug trials attempt to identify those side effects.

Recommended Videos

Almost all of these side effects are undesirable, but many of them are worth the risk as long as they treat the condition. Others, however, can have serious consequences.

Now a new technology called a microphysiological system — or “body on a chip” — may help identify potential problems faster. Developed by engineers at the Massachusetts Institute of Technology (MIT) the device is made up of a microfluid medium that connects tissues engineered from up to 10 different organs, allowing it to mimic mechanisms of the human body for weeks on end. With this system, which was detailed in a paper published last week in the journal Scientific Reports, the researchers hope to reveal how drugs designed to treat a specific organ might have an effect on other organs in the body.

“Some of these effects are really hard to predict from animal models because the situations that lead to them are idiosyncratic,” Linda Griffith, a professor of biological and mechanical engineering, and one of the senior authors of the study, said in a statement. “With our chip, you can distribute a drug and then look for the effects on other tissues, and measure the exposure and how it is metabolized.”

After researchers develop a pharmaceutical drug, they test it through a series of preclinical animal trials intended to demonstrate the drug’s safety and effectiveness. However, Griffith points out, humans aren’t exactly like other animals. Sure, we share a similar biology with lab animals, but the relation isn’t always one to one.

“Animals do not represent people in all the facets that you need to develop drugs and understand disease,” she said. “That is becoming more and more apparent as we look across all kinds of drugs.”

To get around this obstacle without testing on human subjects, researchers have developed “organs on chips,” miniature replicas of organs composed of engineered tissue.

While the basis of this technology isn’t anything new, Griffith and her colleagues are the first to fit so many tissue types onto a single open chip, enabling them to manipulate and remove samples.

The organ tissue types fit onto the chip include liver, lung, gut, endometrium, brain, heart, pancreas, kidney, skin, and skeletal muscle, each containing between 1 million and 2 million cells.

While the system is promising, it won’t be used to its full potential anytime soon. For now, Griffith and her team are using the system for more restrained studies, including just a few organs like brain, liver, and gastrointestinal tissue to model Parkinson’s disease.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Volkswagen plans 8 new affordable EVs by 2027, report says
volkswagen affordable evs 2027 id 2all

Back in the early 1970s, when soaring oil prices stifled consumer demand for gas-powered vehicles, Volkswagen took a bet on a battery system that would power its first-ever electric concept vehicle, the Elektro Bus.
Now that the German automaker is facing a huge slump in sales in Europe and China, it’s again turning to affordable electric vehicles to save the day.Volkswagen brand chief Thomas Schaefer told German media that the company plans to bring eight new affordable EVs to market by 2027."We have to produce our vehicles profitably and put them on the road at affordable prices," he is quoted as saying.
One of the models will be the ID.2all hatchback, the development of which is currently being expedited to 36 months from its previous 50-month schedule. Last year, VW unveiled the ID.2all concept, promising to give it a price tag of under 25,000 euros ($27,000) for its planned release in 2025.VW CEO Larry Blume has also hinted at a sub-$22,000 EV to be released after 2025.It’s unclear which models would reach U.S. shores. Last year, VW America said it planned to release an under-$35,000 EV in the U.S. by 2027.The price of batteries is one of the main hurdles to reduced EV’s production costs and lower sale prices. VW is developing its own unified battery cell in several European plants, as well as one plant in Ontario, Canada.But in order for would-be U.S. buyers to obtain the Inflation Reduction Act's $7,500 tax credit on the purchase of an EV, the vehicle and its components, including the battery, must be produced at least in part domestically.VW already has a plant in Chattanooga, Tennesse, and is planning a new plant in South Carolina. But it’s unclear whether its new unified battery cells would be built or assembled there.

Read more
Nissan launches charging network, gives Ariya access to Tesla SuperChargers
nissan charging ariya superchargers at station

Nissan just launched a charging network that gives owners of its EVs access to 90,000 charging stations on the Electrify America, Shell Recharge, ChargePoint and EVgo networks, all via the MyNissan app.It doesn’t stop there: Later this year, Nissan Ariya vehicles will be getting a North American Charging Standard (NACS) adapter, also known as the Tesla plug. And in 2025, Nissan will be offering electric vehicles (EVs) with a NACS port, giving access to Tesla’s SuperCharger network in the U.S. and Canada.Starting in November, Nissan EV drivers can use their MyNissan app to find charging stations, see charger availability in real time, and pay for charging with a payment method set up in the app.The Nissan Leaf, however, won’t have access to the functionality since the EV’s charging connector is not compatible. Leaf owners can still find charging stations through the NissanConnectEV and Services app.Meanwhile, the Nissan Ariya, and most EVs sold in the U.S., have a Combined Charging System Combo 1 (CCS1) port, which allows access to the Tesla SuperCharger network via an adapter.Nissan is joining the ever-growing list of automakers to adopt NACS. With adapters, EVs made by General Motors, Ford, Rivian, Honda and Volvo can already access the SuperCharger network. Kia, Hyundai, Toyota, BMW, Volkswagen, and Jaguar have also signed agreements to allow access in 2025.
Nissan has not revealed whether the adapter for the Ariya will be free or come at a cost. Some companies, such as Ford, Rivian and Kia, have provided adapters for free.
With its new Nissan Energy Charge Network and access to NACS, Nissan is pretty much covering all the bases for its EV drivers in need of charging up. ChargePoint has the largest EV charging network in the U.S., with over 38,500 stations and 70,000 charging ports at the end of July. Tesla's charging network is the second largest, though not all of its charging stations are part of the SuperCharger network.

Read more
Juiced Bikes sold at auction for $1.2 million, report says
The Juiced Bikes Scorpion X2 adds more power, upgraded tires, and an improved battery to the popular moped style e-bike.

Juiced Bikes, the San Diego-based maker of e-bikes, has been sold on an auction website for $1,225,000, according to a report from Electrek.Digital Trends recently reported how the company was showing signs of being on the brink of bankruptcy. The company and its executives had remained silent, while customer inquiries went unanswered and its website showed all products were out of stock. In addition, there were numerous reports of layoffs at the company.Yet, the most convincing sign was that the company’s assets appeared as listed for sale on an auction website used by companies that go out of business.Now, it appears that Juiced Bikes’ assets, including a dozen patents, multiple URLs, and the company’s inventory in both the U.S. and China, have been sold at auction, according to the report. It is likely that the buyer, who remains unknown, can capitalize on the brand and the overall value of the 15-year old company. Founded in 2009 by Tora Harris, a U.S. high-jump Olympian, Juiced Bikes was one of the early pioneers of the direct-to-consumer e-bike brands in the U.S. market.
The company had quickly built a reputation for the versatility of its e-bikes and the durability of their batteries. Over the years, the popularity of models such as the CrossCurrent, HyperScrambler, and RipCurrent only bolstered the brand’s status.Last year, Digital Trends named the Juiced Bikes Scorpion X2 as the best moped-style e-bike for 2023, citing its versatility, rich feature set, and performance.Juiced Bikes’ getting sold quickly might be a sign of what consulting firm Houlihan Lokey says is a recovery in the North American e-bike market.
The industry has had a roller-coaster ride during and after the COVID-19 pandemic: A huge spike in demand for e-bikes had combined with disrupted supply chains to create a supply/demand mismatch of “historic proportions," Houlihan Lokey said.

Read more